Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-08 00:56 | 2025-03-05 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $66.35 | 7,513 | $498,488 | 8,394 | -47.2% |
| 2023-08-05 00:41 | 2023-08-03 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | SALE | $74.92 | 25,759 | $1,930,004 | 4,698 | -84.6% |
| 2022-02-02 00:43 | 2022-01-28 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $109.00 | 6,059 | $660,431 | 17,497 | -25.7% |
| 2021-04-02 00:31 | 2021-03-31 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $76.00 | 5,350 | $406,600 | 7,244 | -42.5% |
| 2020-05-28 23:49 | 2020-05-26 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | SALE | $65.00 | 270 | $17,550 | 4,547 | -5.6% |
| 2020-05-01 00:22 | 2020-04-28 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | SALE | $65.00 | 6,234 | $405,210 | 4,817 | -56.4% |
| 2020-04-02 00:14 | 2020-03-30 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $60.00 | 3,030 | $181,800 | 9,760 | -23.7% |
| 2019-03-02 01:45 | 2019-03-01 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $58.14 | 1,664 | $96,745 | 6,893 | -19.4% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.